Silibinin suppresses epithelial-mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1.

Conclusions: These findings shown an anti-tumor impact of silibinin on NSCLC cells via repression of RHBDD1.
PMID: 32528541 [PubMed - in process]

Source: Cellular and Molecular Biology Letters - June 14, 2020 Category: Biochemistry Authors: Xu S, Zhang H, Wang A, Ma Y, Gan Y, Li G Tags: Cell Mol Biol Lett Source Type: research